methazolamide has been researched along with Achromatopsia in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Achromatopsia: Severely deficient color perception, typically with monochromacy and reduced visual acuity. The atypical form can include normal visual acuity with pseudomonochromacy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Widengård, I | 1 |
| Mandahl, A | 1 |
| Törnquist, P | 1 |
| Wistrand, PJ | 1 |
1 trial available for methazolamide and Achromatopsia
| Article | Year |
|---|---|
Colour vision and side-effects during treatment with methazolamide.
Topics: Adult; Carbon Dioxide; Color Vision Defects; Cross-Over Studies; Double-Blind Method; Humans; Intrao | 1995 |